Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does micropapillary subtype for a G1-2 DCIS affect your radiation treatment recommendations?
Are you more likely to recommend radiation over omission? Whole breast over APBI?
Answer from: Radiation Oncologist at Community Practice
It doesn’t change the recommendation. If adequate, imaging and surgery are done, like any other DCIS.
Sign in or Register to read more
28151
Related Questions
How would you approach the treatment of low grade, stage IA, triple negative apocrine adenocarcinoma of the breast in a female patient in her 70s?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
Is it appropriate to use bolus with hypofractionated PMRT?
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
In a patient with cardiac comorbidities, who meets ASTRO APBI criteria other than a positive margin, would you offer APBI in an attempt to reduce cardiac dose?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Would you consider 5-fraction whole breast RT for a patient with multiple positive margins following lumpectomy for whom reexcision is not possible?
How do the results of INSEMA and SOUND impact the decision of omitting SLND in young women with breast cancer and offering adjuvant RT to patients who would otherwise be candidates for omission?